APO Research
Talk to an analyst

APO RESEARCH · REPORT

Keratosis Pilaris Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Keratosis Pilaris Treatment Industry Growth and Trends Forecast to 2032

31 December 2025101 pages

Choose your research edition.

Industry ResearchKeratosis Pilaris Treatment Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Keratosis Pilaris Treatment Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Keratosis Pilaris Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Keratosis Pilaris Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Keratosis Pilaris Treatment Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

According to APO Research, the global Keratosis Pilaris Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Keratosis Pilaris Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Keratosis Pilaris Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Keratosis Pilaris Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Keratosis Pilaris Treatment market include AmLactin (Novartis), CeraVe (L'Oréal), DERMAdoctor, Eucerin (Beiersdorf AG), Excipial (Galderma), First Aid Beauty (P&G), Neutrogena (Johnson & Johnson), Nip + Fab and Paula’s Choice, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Keratosis Pilaris Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Keratosis Pilaris Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Keratosis Pilaris Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Keratosis Pilaris Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Keratosis Pilaris Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Keratosis Pilaris Treatment Market by Company

AmLactin (Novartis)

CeraVe (L'Oréal)

DERMAdoctor

Eucerin (Beiersdorf AG)

Excipial (Galderma)

First Aid Beauty (P&G)

Neutrogena (Johnson & Johnson)

Nip + Fab

Paula’s Choice

SLMD Skincare

Touch Skin Care

Keratosis Pilaris Treatment Segment by Type

Body Scrub

Lotion

Body Wash & Shower Gel

Other

Keratosis Pilaris Treatment Segment by Application

For Body

For Facial Skin

Keratosis Pilaris Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Keratosis Pilaris Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Keratosis Pilaris Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Keratosis Pilaris Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Keratosis Pilaris Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Keratosis Pilaris Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Keratosis Pilaris Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Keratosis Pilaris Treatment Market Share by Region (2021-2026) Table 4. Global Keratosis Pilaris Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Keratosis Pilaris Treatment Market Share by Region (2027-2032) Table 6. Global Keratosis Pilaris Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Keratosis Pilaris Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Keratosis Pilaris Treatment Market Size Share by Type (2021-2026) Table 9. Global Keratosis Pilaris Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Keratosis Pilaris Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Keratosis Pilaris Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Keratosis Pilaris Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Keratosis Pilaris Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Keratosis Pilaris Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Keratosis Pilaris Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Keratosis Pilaris Treatment Market Size Share by Application (2021-2026) Table 24. Global Keratosis Pilaris Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Keratosis Pilaris Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Keratosis Pilaris Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Keratosis Pilaris Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Keratosis Pilaris Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Keratosis Pilaris Treatment Industry Trends Table 37. Keratosis Pilaris Treatment Industry Drivers Table 38. Keratosis Pilaris Treatment Industry Opportunities and Challenges Table 39. Keratosis Pilaris Treatment Industry Restraints Table 40. Global Keratosis Pilaris Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Keratosis Pilaris Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Keratosis Pilaris Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Keratosis Pilaris Treatment Key Company Headquarters & Area Served Table 44. Global Keratosis Pilaris Treatment Company, Product Type & Application Table 45. Global Keratosis Pilaris Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Keratosis Pilaris Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. AmLactin (Novartis) Company Information Table 49. AmLactin (Novartis) Business Overview Table 50. AmLactin (Novartis) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio Table 52. AmLactin (Novartis) Recent Development Table 53. CeraVe (L'Oréal) Company Information Table 54. CeraVe (L'Oréal) Business Overview Table 55. CeraVe (L'Oréal) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio Table 57. CeraVe (L'Oréal) Recent Development Table 58. DERMAdoctor Company Information Table 59. DERMAdoctor Business Overview Table 60. DERMAdoctor Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. DERMAdoctor Keratosis Pilaris Treatment Product Portfolio Table 62. DERMAdoctor Recent Development Table 63. Eucerin (Beiersdorf AG) Company Information Table 64. Eucerin (Beiersdorf AG) Business Overview Table 65. Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio Table 67. Eucerin (Beiersdorf AG) Recent Development Table 68. Excipial (Galderma) Company Information Table 69. Excipial (Galderma) Business Overview Table 70. Excipial (Galderma) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio Table 72. Excipial (Galderma) Recent Development Table 73. First Aid Beauty (P&G) Company Information Table 74. First Aid Beauty (P&G) Business Overview Table 75. First Aid Beauty (P&G) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio Table 77. First Aid Beauty (P&G) Recent Development Table 78. Neutrogena (Johnson & Johnson) Company Information Table 79. Neutrogena (Johnson & Johnson) Business Overview Table 80. Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio Table 82. Neutrogena (Johnson & Johnson) Recent Development Table 83. Nip + Fab Company Information Table 84. Nip + Fab Business Overview Table 85. Nip + Fab Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nip + Fab Keratosis Pilaris Treatment Product Portfolio Table 87. Nip + Fab Recent Development Table 88. Paula’s Choice Company Information Table 89. Paula’s Choice Business Overview Table 90. Paula’s Choice Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Paula’s Choice Keratosis Pilaris Treatment Product Portfolio Table 92. Paula’s Choice Recent Development Table 93. SLMD Skincare Company Information Table 94. SLMD Skincare Business Overview Table 95. SLMD Skincare Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. SLMD Skincare Keratosis Pilaris Treatment Product Portfolio Table 97. SLMD Skincare Recent Development Table 98. Touch Skin Care Company Information Table 99. Touch Skin Care Business Overview Table 100. Touch Skin Care Keratosis Pilaris Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Touch Skin Care Keratosis Pilaris Treatment Product Portfolio Table 102. Touch Skin Care Recent Development Table 103. North America Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Keratosis Pilaris Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Keratosis Pilaris Treatment Market Share by Country (2021-2026) Table 106. North America Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Keratosis Pilaris Treatment Market Share Forecast by Country (2027-2032) Table 108. Europe Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Keratosis Pilaris Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Keratosis Pilaris Treatment Market Share by Country (2021-2026) Table 111. Europe Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Keratosis Pilaris Treatment Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Keratosis Pilaris Treatment Market Share by Country (2021-2026) Table 116. Asia-Pacific Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Keratosis Pilaris Treatment Market Share Forecast by Country (2027-2032) Table 118. Latin America Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Keratosis Pilaris Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Keratosis Pilaris Treatment Market Share by Country (2021-2026) Table 121. Latin America Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Keratosis Pilaris Treatment Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Keratosis Pilaris Treatment Market Share by Country (2021-2026) Table 126. Middle East & Africa Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Keratosis Pilaris Treatment Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Keratosis Pilaris Treatment Product Image Figure 3. Global Keratosis Pilaris Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Keratosis Pilaris Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Keratosis Pilaris Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Keratosis Pilaris Treatment Market Share by Region (2021-2032) Figure 7. North America Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Body Scrub Image Figure 13. Global Body Scrub Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Lotion Image Figure 15. Global Lotion Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Body Wash & Shower Gel Image Figure 17. Global Body Wash & Shower Gel Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Image Figure 19. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Keratosis Pilaris Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Keratosis Pilaris Treatment Market Share by Type 2025 VS 2032 Figure 22. North America Keratosis Pilaris Treatment Market Size Share by Type (2021-2032) Figure 23. Europe Keratosis Pilaris Treatment Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Keratosis Pilaris Treatment Market Size Share by Type (2021-2032) Figure 25. Latin America Keratosis Pilaris Treatment Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Keratosis Pilaris Treatment Market Size Share by Type (2021-2032) Figure 27. For Body Image Figure 28. Global For Body Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. For Facial Skin Image Figure 30. Global For Facial Skin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Keratosis Pilaris Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Keratosis Pilaris Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Keratosis Pilaris Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Keratosis Pilaris Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Keratosis Pilaris Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Keratosis Pilaris Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Keratosis Pilaris Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Keratosis Pilaris Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Keratosis Pilaris Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Keratosis Pilaris Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Keratosis Pilaris Treatment Market Share by Country (2021-2032) Figure 43. Europe Keratosis Pilaris Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Keratosis Pilaris Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Keratosis Pilaris Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Keratosis Pilaris Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Keratosis Pilaris Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Keratosis Pilaris Treatment Market Share by Country (2021-2032) Figure 49. Latin America Keratosis Pilaris Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Keratosis Pilaris Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Keratosis Pilaris Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Keratosis Pilaris Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Keratosis Pilaris Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Keratosis Pilaris Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Body Scrub
  • Lotion
  • Body Wash & Shower Gel
  • Other
Applications
  • For Body
  • For Facial Skin
Companies covered
  • AmLactin (Novartis)
  • CeraVe (L'Oréal)
  • DERMAdoctor
  • Eucerin (Beiersdorf AG)
  • Excipial (Galderma)
  • First Aid Beauty (P&G)
  • Neutrogena (Johnson & Johnson)
  • Nip + Fab
  • Paula’s Choice
  • SLMD Skincare
  • Touch Skin Care

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Keratosis Pilaris Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Keratosis Pilaris Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Keratosis Pilaris Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Keratosis Pilaris Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Keratosis Pilaris Treatment Market Size (2021-2032)
  8. 1.5.1 North America Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Keratosis Pilaris Treatment Market Size Growth Rate (2021-2032)
2 Keratosis Pilaris Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Body Scrub
  3. 2.1.2 Lotion
  4. 2.1.3 Body Wash & Shower Gel
  5. 2.1.4 Other
  6. 2.2 Global Keratosis Pilaris Treatment Market Size by Type
  7. 2.2.1 Global Keratosis Pilaris Treatment Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Keratosis Pilaris Treatment Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Keratosis Pilaris Treatment Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Keratosis Pilaris Treatment Market Size by Regions
  11. 2.3.1 North America Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Type (2021-2026)
3 Keratosis Pilaris Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 For Body
  3. 3.1.2 For Facial Skin
  4. 3.2 Global Keratosis Pilaris Treatment Market Size by Application
  5. 3.2.1 Global Keratosis Pilaris Treatment Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Keratosis Pilaris Treatment Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Keratosis Pilaris Treatment Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Keratosis Pilaris Treatment Market Size by Regions
  9. 3.3.1 North America Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Keratosis Pilaris Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Keratosis Pilaris Treatment Industry Trends
  2. 4.2 Keratosis Pilaris Treatment Industry Drivers
  3. 4.3 Keratosis Pilaris Treatment Industry Opportunities and Challenges
  4. 4.4 Keratosis Pilaris Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Keratosis Pilaris Treatment Revenue (2021-2026)
  2. 5.2 Global Keratosis Pilaris Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Keratosis Pilaris Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Keratosis Pilaris Treatment Company, Product Type & Application
  5. 5.5 Global Keratosis Pilaris Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Keratosis Pilaris Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Keratosis Pilaris Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Keratosis Pilaris Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 AmLactin (Novartis)
  2. 6.1.1 AmLactin (Novartis) Company Information
  3. 6.1.2 AmLactin (Novartis) Business Overview
  4. 6.1.3 AmLactin (Novartis) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 AmLactin (Novartis) Keratosis Pilaris Treatment Product Portfolio
  6. 6.1.5 AmLactin (Novartis) Recent Developments
  7. 6.2 CeraVe (L'Oréal)
  8. 6.2.1 CeraVe (L'Oréal) Company Information
  9. 6.2.2 CeraVe (L'Oréal) Business Overview
  10. 6.2.3 CeraVe (L'Oréal) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CeraVe (L'Oréal) Keratosis Pilaris Treatment Product Portfolio
  12. 6.2.5 CeraVe (L'Oréal) Recent Developments
  13. 6.3 DERMAdoctor
  14. 6.3.1 DERMAdoctor Company Information
  15. 6.3.2 DERMAdoctor Business Overview
  16. 6.3.3 DERMAdoctor Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 DERMAdoctor Keratosis Pilaris Treatment Product Portfolio
  18. 6.3.5 DERMAdoctor Recent Developments
  19. 6.4 Eucerin (Beiersdorf AG)
  20. 6.4.1 Eucerin (Beiersdorf AG) Company Information
  21. 6.4.2 Eucerin (Beiersdorf AG) Business Overview
  22. 6.4.3 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eucerin (Beiersdorf AG) Keratosis Pilaris Treatment Product Portfolio
  24. 6.4.5 Eucerin (Beiersdorf AG) Recent Developments
  25. 6.5 Excipial (Galderma)
  26. 6.5.1 Excipial (Galderma) Company Information
  27. 6.5.2 Excipial (Galderma) Business Overview
  28. 6.5.3 Excipial (Galderma) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Excipial (Galderma) Keratosis Pilaris Treatment Product Portfolio
  30. 6.5.5 Excipial (Galderma) Recent Developments
  31. 6.6 First Aid Beauty (P&G)
  32. 6.6.1 First Aid Beauty (P&G) Company Information
  33. 6.6.2 First Aid Beauty (P&G) Business Overview
  34. 6.6.3 First Aid Beauty (P&G) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 First Aid Beauty (P&G) Keratosis Pilaris Treatment Product Portfolio
  36. 6.6.5 First Aid Beauty (P&G) Recent Developments
  37. 6.7 Neutrogena (Johnson & Johnson)
  38. 6.7.1 Neutrogena (Johnson & Johnson) Company Information
  39. 6.7.2 Neutrogena (Johnson & Johnson) Business Overview
  40. 6.7.3 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Neutrogena (Johnson & Johnson) Keratosis Pilaris Treatment Product Portfolio
  42. 6.7.5 Neutrogena (Johnson & Johnson) Recent Developments
  43. 6.8 Nip + Fab
  44. 6.8.1 Nip + Fab Company Information
  45. 6.8.2 Nip + Fab Business Overview
  46. 6.8.3 Nip + Fab Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nip + Fab Keratosis Pilaris Treatment Product Portfolio
  48. 6.8.5 Nip + Fab Recent Developments
  49. 6.9 Paula’s Choice
  50. 6.9.1 Paula’s Choice Company Information
  51. 6.9.2 Paula’s Choice Business Overview
  52. 6.9.3 Paula’s Choice Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Paula’s Choice Keratosis Pilaris Treatment Product Portfolio
  54. 6.9.5 Paula’s Choice Recent Developments
  55. 6.10 SLMD Skincare
  56. 6.10.1 SLMD Skincare Company Information
  57. 6.10.2 SLMD Skincare Business Overview
  58. 6.10.3 SLMD Skincare Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 SLMD Skincare Keratosis Pilaris Treatment Product Portfolio
  60. 6.10.5 SLMD Skincare Recent Developments
  61. 6.11 Touch Skin Care
  62. 6.11.1 Touch Skin Care Company Information
  63. 6.11.2 Touch Skin Care Business Overview
  64. 6.11.3 Touch Skin Care Keratosis Pilaris Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Touch Skin Care Keratosis Pilaris Treatment Product Portfolio
  66. 6.11.5 Touch Skin Care Recent Developments
7 North America
  1. 7.1 North America Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Keratosis Pilaris Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Keratosis Pilaris Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Keratosis Pilaris Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Keratosis Pilaris Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Keratosis Pilaris Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Keratosis Pilaris Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Keratosis Pilaris Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst